Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation
Clinical trial NCT06717958 · RECRUITING
Trial details
- NCT number
- NCT06717958
- Sponsor
- Technische Universität Dresden
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-17
- Primary completion
- 2029-10-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.